{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:16:31Z","timestamp":1793304991159,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1245\/s10434-021-10372-9","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T22:04:31Z","timestamp":1625263471000},"page":"126-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei"],"prefix":"10.1245","volume":"29","author":[{"given":"\u00c1lvaro","family":"Arjona-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Valenzuela-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Rufi\u00e1n-And\u00fajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Rufi\u00e1n-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Casado-Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"S\u00e1nchez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Rodr\u00edguez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Medina-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"D\u00edaz-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Granados-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Ortega-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Tena-Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Brice\u00f1o-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Romero-Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"10372_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","volume":"33","author":"R Mittal","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;33:511\u20139.","journal-title":"Int J Hyperthermia."},{"issue":"1","key":"10372_CR2","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.ejso.2020.02.012","volume":"47","author":"K Govaerts","year":"2021","unstructured":"Govaerts K, Lurvink RJ, De Hingh IHJT, et al. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47(1):S11-35.","journal-title":"Eur J Surg Oncol."},{"key":"10372_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process. Am J Surg Pathol. 2016;40:14\u201326.","journal-title":"Am J Surg Pathol."},{"key":"10372_CR4","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1245\/s10434-020-09560-w","volume":"28","author":"B Rufian-Andujar","year":"2021","unstructured":"Rufian-Andujar B, Valenzuela-Molina F, Rufian-Pe\u00f1a S, et al. From the Ronnett to the PSOGI classification system for pseudomyxoma peritonei: a validation study. Ann Surg Oncol. 2021;28:2819\u201327.","journal-title":"Ann Surg Oncol."},{"issue":"Suppl 1","key":"10372_CR5","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.21037\/jgo-20-136","volume":"12","author":"C Lund-Andersen","year":"2021","unstructured":"Lund-Andersen C, Torgunrud A, Fleten KG, Flatmark K. Omics analyses in peritoneal metastasis\u2014utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review. J Gastrointest Oncol. 2021;12(Suppl 1):S191\u2013203.","journal-title":"J Gastrointest Oncol."},{"key":"10372_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jss.2012.10.053","volume":"180","author":"S Shetty","year":"2013","unstructured":"Shetty S, Thomas P, Ramanan B, et al. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis. J Surg Res. 2013;180:97\u2013103.","journal-title":"J Surg Res."},{"key":"10372_CR7","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1093\/annonc\/mdw314","volume":"27","author":"F Pietrantonio","year":"2016","unstructured":"Pietrantonio F, Perrone F, Mennitto A, et al. Toward the molecular dissection of peritoneal pseudomyxoma. Ann Oncol. 2016;27:2097\u2013103.","journal-title":"Ann Oncol"},{"key":"10372_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2019.12.008","volume":"97","author":"F Yan","year":"2020","unstructured":"Yan F, Lin Y, Zhou Q, et al. Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases. Hum Pathol. 2020;97:9\u201318.","journal-title":"Hum Pathol."},{"key":"10372_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2019.01.011","volume":"491","author":"SS Menona","year":"2019","unstructured":"Menona SS, Guruvayoorappan C, Sakthivelc KM, Rasmi RR. Ki-67 protein as a tumour proliferation marker. Clin Chim Acta. 2019;491:39\u201345.","journal-title":"Clin Chim Acta."},{"issue":"5","key":"10372_CR10","first-page":"1468","volume":"23","author":"K Shigeki","year":"2015","unstructured":"Shigeki K, Torres Mesa PA, Cabras A, et al. The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2015;23(5):1468\u201373.","journal-title":"Ann Surg Oncol."},{"key":"10372_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"10372_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/bjs.10716","volume":"105","author":"JB Delhorme","year":"2018","unstructured":"Delhorme JB, Severac F, Averous G, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg. 2018;105:668\u201376.","journal-title":"Br J Surg."},{"key":"10372_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.6363","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Barretta F, Yonemura Y, et al. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. JAMA Surg. 2021. https:\/\/doi.org\/10.1001\/jamasurg.2020.6363.","journal-title":"JAMA Surg."},{"key":"10372_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41568-018-0076-6","volume":"18","author":"S Li","year":"2018","unstructured":"Li S, Balmain A, Counter CM. A model for RAS mutation patterns in cancers: finding the sweet spot. Nat Rev Cancer. 2018;18:767\u201377.","journal-title":"Nat Rev Cancer."},{"key":"10372_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S1470-2045(08)70206-7","volume":"9","author":"H Linardou","year":"2008","unstructured":"Linardou H, Issa JD, Kanaloupiti D, et al. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol. 2008;9:962\u201372.","journal-title":"Lancet Oncol."},{"key":"10372_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","volume":"268","author":"MA Schneider","year":"2018","unstructured":"Schneider MA, Eden J, Pache B, et al. Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and HIPEC for peritoneal metastasis of colorectal origin. Ann Surg. 2018;268:845\u201353.","journal-title":"Ann Surg."},{"key":"10372_CR17","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1245\/s10434-019-07378-9","volume":"26","author":"A Arjona-Sanchez","year":"2019","unstructured":"Arjona-Sanchez A, Rodriguez-Ortiz L, Baratti D, et al. RAS mutation decreases overall survival after optimal cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of colorectal peritoneal metastasis: a modification proposal of the peritoneal surface disease severity score. Ann Surg Oncol. 2019;26:2595\u2013604.","journal-title":"Ann Surg Oncol."},{"key":"10372_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1245\/s10434-019-07879-7","volume":"27","author":"A Stein","year":"2020","unstructured":"Stein A, Strong E, Clark Gamblin T, et al. Molecular and genetic markers in appendiceal mucinous tumors: a systematic review. Ann Surg Oncol. 2020;27:85\u201397.","journal-title":"Ann Surg Oncol."},{"key":"10372_CR19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/modpathol.3800212","volume":"17","author":"J Misdraji","year":"2004","unstructured":"Misdraji J, Burgart LJ, Lauwers GY. Defective mismatch repair in the pathogenesis of low-grade appendiceal mucinous neoplasms and adenocarcinomas. Mod Pathol. 2004;17:1447\u201354.","journal-title":"Mod Pathol."},{"key":"10372_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/modpathol.3880572","volume":"15","author":"W Kabbani","year":"2002","unstructured":"Kabbani W, Houlihan P, Luthra R, et al. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol. 2002;15:599\u2013605.","journal-title":"Mod Pathol."},{"key":"10372_CR21","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/cam4.542","volume":"4","author":"R Noguchi","year":"2015","unstructured":"Noguchi R, Yano H, Gohda Y, et al. Molecular profiles of high-grade and low-grade pseudomyxoma peritonei. Cancer Med. 2015;4:1809\u201316.","journal-title":"Cancer Med."},{"key":"10372_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","author":"FT Bosman","year":"2019","unstructured":"Bosman FT, Cameiro F, Hruban R. WHO classification of tumours: digestive system tumours 2019. Lyon Int Agency Res Cancer. 2019. https:\/\/doi.org\/10.1111\/his.13975.","journal-title":"Lyon Int Agency Res Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10372-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10372-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10372-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T18:03:35Z","timestamp":1639677815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10372-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10372"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10372-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\u00c1lvaro Arjona-S\u00e1nchez, Ana Mart\u00ednez-L\u00f3pez, Francisca Valenzuela-Molina, Blanca Rufi\u00e1n-And\u00fajar, Sebasti\u00e1n Rufi\u00e1n-Pe\u00f1a, \u00c1ngela Casado-Adam, Juan Manuel S\u00e1nchez-Hidalgo, Lidia Rodr\u00edguez-Ortiz, Francisco Javier Medina-Fern\u00e1ndez, Cesar D\u00edaz-L\u00f3pez, Melissa Granados-Rodr\u00edguez, Rosa Ortega-Salas, Justo P. Casta\u00f1o, Manuel Tena-Sempere, Javier Brice\u00f1o-Delgado, and Antonio Romero-Ru\u00edz have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}